| Literature DB >> 33442332 |
Nicolas Biot1, Deborah Romito2, Davide Bonifazi2.
Abstract
In this work, we design and synthesize supramolecular 2,5-substituted chalcogenazolo[5,4-β]pyridine (CGP) synthons arranging in supramolecular ribbons at the solid state. A careful choice of the combination of substituents at the 2- and 5-positions on the CGP scaffold is outlined to accomplish supramolecular materials by means of multiple hybrid interactions, comprising both chalcogen and hydrogen bonds. Depending on the steric and electronic properties of the substituents, different solid-state arrangements have been achieved. Among the different moieties on the 5-position, an oxazole unit has been incorporated on the Se- and Te-congeners by Pd-catalyzed cross-coupling reaction and a supramolecular ribbon-like organization was consistently obtained at the solid state.Entities:
Year: 2020 PMID: 33442332 PMCID: PMC7792508 DOI: 10.1021/acs.cgd.0c01318
Source DB: PubMed Journal: Cryst Growth Des ISSN: 1528-7483 Impact factor: 4.076
Figure 1Representation of the design of 2- and 5-substituted CGP scaffold with the recognition modes expected by modulating the repulsive interactions (e.g., steric or electrostatic) between the 2- and the 5-substituents (i.e., green and orange): frontal EB dimers (A), head-to-tail ribbon- (B) and wire-like (C) organizations.
Scheme 1Synthetic Pathway to 2,5-Functionalized CGP Derivatives
Reagents and conditions: (a) NBS, MeCN, r.t., 5 min; (b) 1. n-BuLi, THF, 0 °C, 10 min; 2. i-PrBu2MgLi·LiCl, 0 °C, 1 h; 3. E0, r.t., overnight; 4. Se: K3Fe(CN)6, H2O, r.t., 10 min; Te: NH4Cl, H2O, air, r.t., 2 h; (c) 1. NaBH4, MeOH, THF, r.t., 1 h; 2. MeI, r.t., 1.5 h; (d) 1. (CF3CO)2O, CH2Cl2, pyridine, 0 °C to r.t., overnight; 2. POCl3, DIPEA, 1,4-dioxane, reflux, overnight; (e) acyl chloride, CH2Cl2, pyridine, 0 °C to r.t., overnight; (f) POCl3, DIPEA, 1,4-dioxane, reflux, overnight; (g) AcCl, NaI, MeCN, 80 °C, MW, 12 h; (h) oxazol-2-ylzinc(II) chloride, [Pd(PPh3)4] 10 mol %, THF, reflux, 2 h.
Figure 2X-ray structures and their respective ESP maps of (a) Me-Te-CF, (c) Cl-Se-CF, and (e) Cl-Te-CF; π–π stacking arrangements of (b) Me-Te-CF, (d) Cl-Se-CF, and (f) Cl-Te-CF. Space group: P21/m. Crystallization solvent: CHCl3.
Figure 3X-ray structures and their ESP maps of (a) I-Te-CF and (d) I-Se-CF; (b) kinked ribbon of I-Te-CF; columnar orientations of (c) I-Te-CF and (e) I-Se-CF (the halogen-bonding and F···F contacts are also displayed). Space groups: C2/c for I-Te-CF, Cmca for I-Se-CF. Crystallization solvent: CHCl3.
Figure 4X-ray structures and their ESP maps of (a) Cl-Te-Th and (b) Cl-Te-Ph, chalcogen bonds are highlighted; wire-like supramolecular architectures of (d) Cl-Te-Ph and (e) I-Te-Ph; stick representation of columnar arrangements of (c) Cl-Te-Ph and (f) I-Te-Ph, with π–π stacking and halogen-bonding interactions highlighted. H atoms are omitted for clarity. Space groups: Pbac for I-Te-Ph, P21/c for Cl-Te-Th and Cl-Te-Ph. Crystallization solvent: CHCl3.
Figure 5X-ray structures and their ESP maps of (a) Ox-Te-CF and (c) Ox-Se-CF; stick representation of the π–π stacking of (b) Ox-Te-CF and (d) Ox-Se-CF. H atoms are omitted for clarity. Space groups: Pnma for Ox-Te-CF, P21/c for Ox-Se-CF. Crystallization solvents: EtOH for Ox-Te-CF, C6H6 for Ox-Se-CF.